Cepheid Tests Target Rapid ID Of Resistant Bugs, Dovetail With Policy Trends
This article was originally published in The Gray Sheet
Cepheid launched two tests last week to help hospitals manage challenging infections that can take hold during a patient's stay
You may also be interested in...
Using a rapid molecular assay to screen all surgical patients on admission for a prevalent drug-resistant infection did not reduce the incidence of hospital-acquired infections in a Swiss study involving more than 20,000 patients
The market for sophisticated gene tests has the potential to greatly expand with the introduction of new "push-button" systems that require less expertise to operate
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.